| Serial Number | 97810745 |
| Word Mark | TRIVENI |
| Filing Date | Friday, February 24, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, October 15, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 15, 2024 |
| Goods and Services | Pharmaceutical, therapeutic and biopharmaceutical agents for treatment of immunological and inflammatory disorders; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for treatment of genetic disorders, cardiovascular diseases, respiratory diseases, infectious diseases, retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases, eye diseases and disorders, intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases; biological preparations, namely, antibodies for medical purposes |
| Goods and Services | Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; scientific research, namely, genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research, namely, DNA analysis and sequencing services for scientific and research purposes; scientific research, development and scientific research consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 15, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TRIVENI BIO, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | WALTHAM, MA 02453 |
| Party Name | TRIVENI BIO, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | WALTHAM, MA 02453 |
| Party Name | Amagma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02453 |
| Event Date | Event Description |
| Wednesday, March 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 25, 2023 | ASSIGNED TO EXAMINER |
| Thursday, November 30, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 30, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, November 30, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 17, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, January 5, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, January 5, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, May 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 4, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, June 4, 2024 | FINAL REFUSAL WRITTEN |
| Tuesday, June 4, 2024 | FINAL REFUSAL E-MAILED |
| Monday, July 8, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, July 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, July 8, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, September 3, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 3, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 11, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 25, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 15, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 15, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |